Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

DSMB recommends continuation of Opexa's phase IIb TERMS study of Tovaxin in MS

March 12, 2008

Mechanism of AMPA receptor antagonist protection against viral encephalomyelitis explored

March 12, 2008

New agents for treating neurological disorders reported in recent patents

March 12, 2008

Strong immunosuppression by natural compound improves EAE in mice

March 12, 2008

Bionomis begins dose-finding preclinical study of its anti-anxiety candidate BNC-210

March 11, 2008

Evidence links 5-HT2A-mGluR2 complex to psychosis

March 11, 2008

Neuroprotective synergy seen with lithium and valproic acid in vitro

March 11, 2008

Anesiva submits sNDA for Zingo for needle insertion pain in adults

March 11, 2008

Recent UCB and Pierre Fabre patents report new compounds for treating neurological disorders

March 11, 2008

ProStrakan receives Swedish marketing authorization for Rapinyl in breakthrough cancer pain

March 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...